The company sees 2011 EPS estimates to $3.38 to $3.40, from $3.38 to $3.44 per share, vs.
Medtronic (NYSE:MDT) reported Q3 EPS of $0.86, ahead of consensus estimates of $0.84 per share. Revenues for the quarter rose 3% year-over-year to $3.96 billion, missing consensus estimates of $3.97 billion.
